Clinical Trials in Maryland

Showing 3161-3180 of 11,119 trials

NXT Post-Market Clinical Follow-up

NCT06336304

NXT Urodynamics System Post-Market Clinical Follow-up Clinical Investigation to Confirm Ongoing Safety and Performance in Urodynamic Patient Sub-Populations

Urinary IncontinenceUrinary ObstructionUrinary Bladder, Overactive+2 more

Laborie Medical Technologies Inc.180 participantsStarted Jun 2024

Hanover, Maryland, United States • Owing Mills, Maryland, United States • Columbus, Ohio, United States +1 more locations

COMPLETEDPhase 213 miles

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

NCT04380805

This is a Phase 2, global, multicenter, open label, single arm study designed to evaluate the efficacy, safety, tolerability, pharmacokinetic (PK), and immunogenicity of AK104 monotherapy in adult subjects with previously treated recurrent or metastatic cervical carcinoma.

Recurrent Cervical CancerMetastatic Cervical Cancer

Akeso30 participantsStarted Jul 2020

Newport Beach, California, United States • Miami, Florida, United States • Plantation, Florida, United States +22 more locations

NXT Post-Market Clinical Follow-up

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

Find Trials by Condition in Maryland

Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence

A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans

A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.

XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Multicenter Hologic Tomosynthesis Study

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Study to Evaluate the OrthoCor Active System for Pain Relief

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis